Taiho Oncology, Inc.

This study tested an experimental pill called futibatinib in people with advanced cancers that have specific changes in genes called FGFR. It enrolled 115 patients into three groups based on their cancer type and specific gene change. The goal was to see if the daily pill could s…

This was an early safety study of a new oral drug called TAS2940 for people with advanced solid tumors that have specific genetic changes (EGFR or HER2). The main goals were to find a safe dose and see how the body processes the drug. The trial was terminated and enrolled 29 part…

This study tested whether combining two targeted drugs could help control advanced bladder cancer that had spread. It was for patients who could not receive standard platinum-based chemotherapy. The trial was terminated early and enrolled 43 participants to measure how well the t…

This study tested a drug called futibatinib, alone or with hormone therapy, for people with advanced breast cancer that had spread and had specific genetic changes (FGFR gene amplifications). The goal was to see if the treatment could shrink tumors or control the cancer's growth.…